Paige, the computational pathology startup, has raised $20M as a Series B extension from investors that include Goldman Sachs Merchant Banking Division and HealthCor Partners. This funding brings the total Series B round to $70M. Founded by David Klimstra, Norman Selby, and Thomas Fuchs in 2018, Paige has now raised a total of $95M in reported equity funding. AlleyWatch profiled Paige back in February – Paige Powers the AI-Driven Diagnosis and Treatment of Cancer at Scale Like Never Before
The AlleyWatch audience is driving progress and innovation on a global scale. With its regional media properties, AlleyWatch serves as the highway for technology and entrepreneurship. There are a number of options to reach this audience of the world’s most innovative organizations and startups at scale including having prominent brand placement in a high-visibility piece like this, which will be read by the vast majority of key influencers in the New York business community and beyond. Find out more here.